Cheng-Bo Han1, Wei-Li Wang2, Leslie Quint3, Jian-Xin Xue4, Martha Matuszak3, Randall Ten Haken3, Feng-Ming Spring Kong5. 1. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China. 2. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, Fourth Hospital of China Medical University, Shenyang, China. 3. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. 4. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China. 5. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: fkong@gru.edu.
Abstract
PURPOSE: To investigate whether high-dose radiation to the pulmonary artery (PA) affects overall survival (OS) in patients with non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Patients with medically inoperable/unresectable NSCLC treated with definitive radiation therapy in prospective studies were eligible for this study. Pulmonary artery involvement was defined on the basis of pretreatment chest CT and positron emission tomography/CT fusion. Pulmonary artery was contoured according to the Radiation Therapy Oncology Group protocol 1106 atlas, and dose-volume histograms were generated. RESULTS: A total of 100 patients with a minimum follow-up of 1 year for surviving patients were enrolled: 82.0% underwent concurrent chemoradiation therapy. Radiation dose ranged from 60 to 85.5 Gy in 30-37 fractions. Patients with PA invasion of grade ≤2, 3, 4, and 5 had 1-year OS and median survival of 67% and 25.4 months (95% confidence interval [CI] 15.7-35.1), 62% and 22.2 months (95% CI 5.8-38.6), 90% and 35.8 months (95% CI 28.4-43.2), and 50% and 7.0 months, respectively (P=.601). Two of the 4 patients with grade 5 PA invasion died suddenly from massive hemorrhage at 3 and 4.5 months after completion of radiation therapy. Maximum and mean doses to PA were not significantly associated with OS. The V45, V50, V55, and V60 of PA were correlated significantly with a worse OS (P<.05). Patients with V45 >70% or V60 >37% had significantly worse OS (13.3 vs 37.9 months, P<.001, and 13.8 vs 37.9 months, P=.04, respectively). CONCLUSIONS: Grade 5 PA invasion and PA volume receiving more than 45-60 Gy may be associated with inferior OS in patients with advanced NSCLC treated with concurrent chemoradiation.
PURPOSE: To investigate whether high-dose radiation to the pulmonary artery (PA) affects overall survival (OS) in patients with non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Patients with medically inoperable/unresectable NSCLC treated with definitive radiation therapy in prospective studies were eligible for this study. Pulmonary artery involvement was defined on the basis of pretreatment chest CT and positron emission tomography/CT fusion. Pulmonary artery was contoured according to the Radiation Therapy Oncology Group protocol 1106 atlas, and dose-volume histograms were generated. RESULTS: A total of 100 patients with a minimum follow-up of 1 year for surviving patients were enrolled: 82.0% underwent concurrent chemoradiation therapy. Radiation dose ranged from 60 to 85.5 Gy in 30-37 fractions. Patients with PA invasion of grade ≤2, 3, 4, and 5 had 1-year OS and median survival of 67% and 25.4 months (95% confidence interval [CI] 15.7-35.1), 62% and 22.2 months (95% CI 5.8-38.6), 90% and 35.8 months (95% CI 28.4-43.2), and 50% and 7.0 months, respectively (P=.601). Two of the 4 patients with grade 5 PA invasion died suddenly from massive hemorrhage at 3 and 4.5 months after completion of radiation therapy. Maximum and mean doses to PA were not significantly associated with OS. The V45, V50, V55, and V60 of PA were correlated significantly with a worse OS (P<.05). Patients with V45 >70% or V60 >37% had significantly worse OS (13.3 vs 37.9 months, P<.001, and 13.8 vs 37.9 months, P=.04, respectively). CONCLUSIONS: Grade 5 PA invasion and PA volume receiving more than 45-60 Gy may be associated with inferior OS in patients with advanced NSCLC treated with concurrent chemoradiation.
Authors: Kwan Ho Cho; Sung Ja Ahn; Hong Ryull Pyo; Kyu-Sik Kim; Young-Chul Kim; Sung Ho Moon; Ji-Youn Han; Heung Tae Kim; Woong Sub Koom; Jin Soo Lee Journal: Int J Radiat Oncol Biol Phys Date: 2008-12-29 Impact factor: 7.038
Authors: Mark A Socinski; David E Morris; Jan S Halle; Dominic T Moore; Thomas A Hensing; Steven A Limentani; Robert Fraser; Maureen Tynan; Andrea Mears; M Patricia Rivera; Frank C Detterbeck; Julian G Rosenman Journal: J Clin Oncol Date: 2004-11-01 Impact factor: 44.544
Authors: K Hayakawa; N Mitsuhashi; S Katano; Y Saito; Y Nakayama; H Sakurai; T Akimoto; M Hasegawa; M Yamakawa; H Niibe Journal: Lung Cancer Date: 2001-04 Impact factor: 5.705
Authors: Robert James Cerfolio; Ayesha S Bryant; Virginia L Jones; Robert Michael Cerfolio Journal: Eur J Cardiothorac Surg Date: 2009-02-23 Impact factor: 4.191
Authors: T Obuchi; S Miyahara; T Higuchi; D Hamatake; T Imakiire; T Ueno; Y Yoshinaga; T Shiraishi; T Shirakusa; A Iwasaki Journal: Thorac Cardiovasc Surg Date: 2009-12 Impact factor: 1.827
Authors: Lujun Zhao; Brady T West; James A Hayman; Susan Lyons; Kemp Cease; Feng-Ming Kong Journal: Int J Radiat Oncol Biol Phys Date: 2007-03-23 Impact factor: 7.038
Authors: Marie Wanet; Antoine Delor; François-Xavier Hanin; Benoît Ghaye; Aline Van Maanen; Vincent Remouchamps; Christian Clermont; Samuel Goossens; John Aldo Lee; Guillaume Janssens; Anne Bol; Xavier Geets Journal: Strahlenther Onkol Date: 2017-07-21 Impact factor: 3.621
Authors: Feng-Ming Kong; Randall K Ten Haken; Matthew Schipper; Kirk A Frey; James Hayman; Milton Gross; Nithya Ramnath; Khaled A Hassan; Martha Matuszak; Timothy Ritter; Nan Bi; Weili Wang; Mark Orringer; Kemp B Cease; Theodore S Lawrence; Gregory P Kalemkerian Journal: JAMA Oncol Date: 2017-10-01 Impact factor: 31.777
Authors: Gerard M Walls; Valentina Giacometti; Aditya Apte; Maria Thor; Conor McCann; Gerard G Hanna; John O'Connor; Joseph O Deasy; Alan R Hounsell; Karl T Butterworth; Aidan J Cole; Suneil Jain; Conor K McGarry Journal: Phys Imaging Radiat Oncol Date: 2022-07-26